ID

12921

Beschreibung

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00004038

Link

https://clinicaltrials.gov/show/NCT00004038

Stichworte

  1. 06.01.16 06.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

6. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00004038

Eligibility Breast Cancer NCT00004038

Criteria
Beschreibung

Criteria

histologically confirmed epithelial breast cancer
Beschreibung

breast cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
at least 3 cutaneous or subcutaneous lesions required
Beschreibung

cutaneous or subcutaneous lesions

Datentyp

boolean

Alias
UMLS CUI [1]
C0221198
measurable disease that includes, but is not limited to, cutaneous or subcutaneous metastases
Beschreibung

measurable disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
patient characteristics:
Beschreibung

patient characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
age: over 18
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
performance status: ecog 0-2
Beschreibung

performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
absolute granulocyte count at least 1,500/mm3
Beschreibung

absolute granulocyte count

Datentyp

boolean

Alias
UMLS CUI [1]
C0857490
hemoglobin greater than 8 g/dl
Beschreibung

hemoglobin

Datentyp

boolean

Alias
UMLS CUI [1]
C0019046
platelet count greater than 100,000/mm3
Beschreibung

platelet count

Datentyp

boolean

Alias
UMLS CUI [1]
C0005821
bilirubin less than 2 mg/dl
Beschreibung

bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
pt/ptt within normal range
Beschreibung

pt/ptt

Datentyp

boolean

Alias
UMLS CUI [1]
C0030605
sgot/sgpt less than 2 times upper limit of normal
Beschreibung

sgot/sgpt

Datentyp

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
creatinine less than 1.8 mg/dl
Beschreibung

creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
not pregnant
Beschreibung

pregnant

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
fertile patients must use effective contraception during and for 3 months after therapy
Beschreibung

contraception

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
prior concurrent therapy:
Beschreibung

prior concurrent therapy:

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
concurrent cytotoxic chemotherapy allowed, if stable and responding
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
at least 4 weeks since prior chemotherapy, if starting a new regimen
Beschreibung

at least 4 weeks since prior chemotherapy, if starting a new regimen

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
at least 4 weeks since radiotherapy
Beschreibung

radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
prior adjuvant radiotherapy to the chest wall allowed
Beschreibung

prior adjuvant radiotherapy to the chest wall allowed

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
at least 6 months since radiotherapy to lesions that are to be injected
Beschreibung

at least 6 months since radiotherapy to lesions that are to be injected

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
recovered from prior therapy
Beschreibung

recovered from prior therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111

Ähnliche Modelle

Eligibility Breast Cancer NCT00004038

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
breast cancer
Item
histologically confirmed epithelial breast cancer
boolean
C0678222 (UMLS CUI [1])
cutaneous or subcutaneous lesions
Item
at least 3 cutaneous or subcutaneous lesions required
boolean
C0221198 (UMLS CUI [1])
measurable disease
Item
measurable disease that includes, but is not limited to, cutaneous or subcutaneous metastases
boolean
C1513041 (UMLS CUI [1])
patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
age
Item
age: over 18
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status: ecog 0-2
boolean
C1520224 (UMLS CUI [1])
absolute granulocyte count
Item
absolute granulocyte count at least 1,500/mm3
boolean
C0857490 (UMLS CUI [1])
hemoglobin
Item
hemoglobin greater than 8 g/dl
boolean
C0019046 (UMLS CUI [1])
platelet count
Item
platelet count greater than 100,000/mm3
boolean
C0005821 (UMLS CUI [1])
bilirubin
Item
bilirubin less than 2 mg/dl
boolean
C1278039 (UMLS CUI [1])
pt/ptt
Item
pt/ptt within normal range
boolean
C0030605 (UMLS CUI [1])
sgot/sgpt
Item
sgot/sgpt less than 2 times upper limit of normal
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
creatinine
Item
creatinine less than 1.8 mg/dl
boolean
C0201976 (UMLS CUI [1])
pregnant
Item
not pregnant
boolean
C0032961 (UMLS CUI [1])
contraception
Item
fertile patients must use effective contraception during and for 3 months after therapy
boolean
C0700589 (UMLS CUI [1])
prior concurrent therapy:
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
chemotherapy
Item
concurrent cytotoxic chemotherapy allowed, if stable and responding
boolean
C0392920 (UMLS CUI [1])
at least 4 weeks since prior chemotherapy, if starting a new regimen
Item
at least 4 weeks since prior chemotherapy, if starting a new regimen
boolean
C0392920 (UMLS CUI [1])
radiotherapy
Item
at least 4 weeks since radiotherapy
boolean
C1522449 (UMLS CUI [1])
prior adjuvant radiotherapy to the chest wall allowed
Item
prior adjuvant radiotherapy to the chest wall allowed
boolean
C1522449 (UMLS CUI [1])
at least 6 months since radiotherapy to lesions that are to be injected
Item
at least 6 months since radiotherapy to lesions that are to be injected
boolean
C1522449 (UMLS CUI [1])
recovered from prior therapy
Item
recovered from prior therapy
boolean
C0087111 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video